Drug Research

Chiesi Global Rare Diseases has entered a co-development agreement with Aliada Therapeutics, a biotechnology company developing a novel blood-brain barrier (BBB)-crossing platform technology to address challenging disease areas with high unmet need.The collaboration will focus on multiple enzyme cargoes...

Croda Pharma has introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need for replacing the popular, but now banned,...

The parenteral drug manufacturing process is anchored by the Supply Chain. The impact of COVID-19 has influenced both positively and negatively the production of contemporary parenteral drugs. Many manufacturers have structured their systems around the lean Just-In-Time (JIT) production...

Lonza has launched the Nebula® Absorbance Reader, a new absorbance microplate reader which joins the company’s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing. Pharmaceutical quality control (QC) laboratories worldwide rely on the traditional absorbance-based Limulus amebocyte lysate (LAL) and Tachypleus amebocyte...

As per insights, a significant increase in the small molecule active pharmaceutical ingredient (API) market has been projected, estimating it to be valued at approximately $284.7 billion by 2032, compared to $162.8 billion in 2022. A compound annual growth...

The healthcare industry is responsible for 4.4% of all greenhouse gas emissions and faces significant challenges in its supply chain, resulting in $35 billion worth of wasted products each year. Startups have emerged as powerful agents of change, leveraging...

Overseeing a pharmaceutical supply chain and ensuring its efficiency is a complex and collaborative endeavor. The process commences with sourcing raw materials, including chemicals and ingredients, which are used to manufacture drugs. These drugs undergo stringent quality checks, formulation,...